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Abstract
Background: Racial/ethnic minorities and men who have sex with men (MSM) represent populations with disparate 
sexually transmitted infection (STI) rates. While race-specific STI rates have been widely reported, STI rates among MSM 
is often challenging given the absence of MSM population estimates. We evaluated the race-specific rates of chlamydia 
and gonorrhea among MSM and non-MSM in San Francisco between 1999-2008.
Methods: 2000 US Census data for San Francisco was used to estimate the number of African-American, Asian/Pacific 
Islander, Hispanic, and white males. Data from National HIV Behavioral Surveillance (NHBS) MSM 1, conducted in 2004, 
was used to estimate the total number of MSM in San Francisco and the size of race/ethnic sub-populations of MSM. 
Non-MSM estimates were calculated by subtracting the number of estimated MSM from the total number of males 
residing in San Francisco. Rates of MSM and non-MSM gonorrhea and chlamydia reported between 1999 and 2008 
were stratified by race/ethnicity. Ratios of MSM and non-MSM rates of morbidity were calculated by race/ethnicity.
Results: Between 1999-2008, MSM accounted for 72% of gonorrhea cases and 51% of chlamydia cases. Throughout 
the study period, African-American MSM had the highest chlamydia rate with 606 cases per 100,000 in 1999 increasing 
to 2067 cases per 100,000 in 2008. Asian/Pacific Islander MSM consistently had the lowest rate among MSM with1003 
cases per 100,000 in 2008. The ratio of MSM/non-MSM for chlamydia was highest among whites 11.6 (95% CI: 8.8-14.4) 
and Asian/Pacific Islanders 8.6 (95% CI: 6.2-11), and lowest among African-Americans 1.53 (95% CI: 1.2-1.9) and 
Hispanics 4.43 (95% CI: 2.8-6.0). Gonorrhea rates were similar for African-American, white, and Hispanic MSM between 
2137-2441 cases per 100,000 in 2008. Asian/Pacific Islander MSM had the lowest gonorrhea rate with 865 cases per 
100,000 in 2008. The ratio of MSM/non-MSM for gonorrhea was highest among whites 11.6 (95% CI: 8.8-14.4) and 
Asian/Pacific Islanders 8.6 (95% CI: 6.2-11), and lowest among African-Americans 1.53 (95% CI: 1.2-1.9) and Hispanics 
4.43 (95% CI: 2.8-6.0).
Conclusions: For all racial/ethnic groups in San Francisco, MSM carried a substantially higher burden of STIs compared 
to non-MSM except among African-American men. These racial and sexual behavior disparities warrant further public 
health attention and resources.
Background
Health disparities among racial and ethnic minorities
have been well documented in the literature, particularly
among Sexually Transmitted Infections (STIs) [1]. Afri-
can-Americans have gonorrhea and chlamydia rates that
are eighteen and eight times higher than whites respec-
tively [2]. Similar disparities ha ve been documented in
San Francisco where African-Americans have signifi-
cantly higher rates of gonorrhea and chlamydia compared
to their white counterparts [3]. Men who have sex with
men (MSM), also represent a population with disparate
rates of STI/HIV compared to heterosexual men [4]. Sev-
eral studies have demonstrated the increased incidence of
STIs among African-American MSM in relation to HIV
risk [5-10]. Furthermore, an overall lower incidence of
STIs among Asian/Pacific Islanders has been reported
[11]. The US Census does not currently capture data on
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sexual orientation or identity; as a result other methodol-
ogies are required to enumerate these populations [12].
Comparing population based STI trends among MSM is
challenging given populations estimates of MSM overall,
or stratified by race, are often unavailable. Consequently
most studies utilize research samples, not county-wide
morbidity data, and no study has looked at a comparison
of men from all major racial/ethnic groups based on sex-
ual behavior.
Racial/ethnic and sexual orientation specific prevalence
of STIs are essential in determining the excess burden
that some racial groups experience but also the increased
STI burden that MSM have over other men. These data
have broad implications including provision and target-
ing of prevention and treatment programs to address
health and healthcare disparities.
The objectives of this study were to evaluate the race-
specific rates of chlamydia and gonorrhea among men in
San Francisco.
Methods
As per Title 17, California Code of Regulations §2500,
§2593, §2641-2643, §2800-2812, lab and provider report-
ing of chlamydia and gonorrhea to the San Francisco
Department of Public Health is mandated. Data on the
case's race/ethnicity (Hispanic/Latino, African Ameri-
can/Black, Asian/Pacific Islander (including Asian-
Indian, Cambodian, Chinese, Filipino, Guamanian,
Hawaiian, Japanese, Korean, Loatian, Samoan, Vietnam-
ese, or "Other"), Native American/Alaskan Native, White,
or "Other") and genders of sex partners are collected
through routine provider and lab based reporting. In San
Francisco, all STI morbidity among males is electronically
matched to any prior episode of the patient (STI clinic
visit, prior reported STI morbidity) to determine if the
patient has documentation of reporting a male partner, a
sexual identity of gay, or a diagnosis of rectal gonorrhea
or rectal chlamydia. These data date back to the 1970s
and we assumed that sexual orientation was fixed; i.e.,
that any previous report of having a male sex partner, gay
sexual identity, or rectal STI was carried forward in time
t o  a n y  s u b s e q u e n t  m o r b i d i t y .  M e n  w h o  r e p o r t e d  b o t h
male and female partners were included in our definition
of MSM. All male reports for gonorrhea or chlamydia
with no history of a male partner, gay identity, or a rectal
infection were assumed to be non-MSM. All male gonor-
rhea and chlamydia morbidity at any site (urogenital, rec-
tal or pharyngeal) among San Francisco residents that
was separated by more than 30 days reported between
1999 and 2008 were included in the analysis.
Data from National HIV Behavioral Surveillance
(NHBS) MSM 1, conducted in 2004, was used to estimate
the total number of MSM in San Francisco [13]. Subse-
quently, subpopulation sizes were projected using the
total population size estimate multiplied by the propor-
tion of sub-populations sampled in NHBS MSM1. For
example, based on NHBS MSM1 data there are an esti-
mated 57,218 MSM in San Francisco. Fifty-six percent of
these MSM were white, providing a population of esti-
mate of 31,788 white MSM. 2000 US Census data for San
Francisco was used to estimate the number of African-
American, Asian/Pacific Islander, Hispanic, and white
males residing in San Francisco [12]. The race/ethnicity
specific non-MSM estimates were calculated by subtract-
ing the number of estimated MSM from the total number
of males residing in San Francisco.
Race/ethnicity-specific rates of MSM and non-MSM
gonorrhea and chlamydia were estimated by dividing the
number of reported cases in each MSM and racial/ethnic
group by the estimated San Francisco population for each
group. MSM to non-MSM racial/ethnic specific rate
ratios were also estimated. As these were de-identified,
publically available surveillance data used for public
health purposes, this study was considered exempt from
human-subjects considerations in accordance with the
Code of Federal Regulations, Title 45, and by the Com-
mittee on Human Research at University of California,
San Francisco.
Results
In total, between 1999 and 2008, there were 15,418 case
of gonorrhea and 14,197 cases of chlamydia reported in
San Francisco. MSM accounted for 72% of the gonorrhea
cases and 51% of the chlamydia cases during that period.
In San Francisco, the estimated number of white MSM
was 31,788, African-American MSM 4,450, Hispanic
MSM 10,808, and Asian/Pacific Islander MSM 10,127.
Among non-MSM in San Francisco, an estimated
147,538 were white, 25,511 were African-American,
47,047 are Hispanic, and 104,810 were Asian/Pacific
Islander.
Chlamydia
In San Francisco, case rates of chlamydia among MSM
increased for all racial groups during the study period
(Figure 1A). African-American MSM consistently had the
highest rates of chlamydia with 606 cases per 100,000 in
1999 and 2067 cases per 100,000 in 2008. Asian/Pacific
Islanders had the lowest case rate during the study period
with 1003 cases per 100,000 in 2008. While rates of MSM
chlamydia appeared to increase over the analytic period,
non-MSM chlamydia rates remained largely stable (Fig-
ure 1B). African-American non-MSM also had the high-
est rates of chlamydia with 1450 cases per 100,000 in
1999 and 1211 cases per 100,000 in 2008. Non-MSM in
all other racial groups had at least a four fold lower case
rate of chlamydia compared to African-Americans. The
rate ratio of MSM/non-MSM was highest among WhitesScott et al. BMC Public Health 2010, 10:315
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Figure 1 Rates of chlamydia among men in San Francisco, 1999-2008. (A) Cases of chlamydia among men who have sex with men (MSM) per 
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11.6 (95% CI: 8.8-14.4) and Asian/Pacific Islanders 8.6
(95% CI: 6.2-11) and lowest among African-Americans
1.53 (95% CI: 1.2-1.9) and Hispanics 4.43 (95% CI: 2.8-
6.0) (Figure 2).
Between 1999 and 2003, 65% to 81% of chlamydia cases
in MSM were diagnosed at the San Francisco STI Clinic
(City Clinic). However, in 2007 only 55% of cases were
diagnosed at City Clinic and 22% were diagnosed by pri-
mary care physicians (compared to 7% in 1999). In con-
trast, non-MSM were diagnosed in similar proportions at
various clinic settings including City Clinic, primary care
offices, hospital, and outreach settings throughout the
study period.
Gonorrhea
Rates of gonorrhea among MSM increased between 1999
and 2008 (Figure 3A). In 2008, African-Americans and
Whites had similar rates of gonorrhea at 2360 per
100,000 and 2441 cases per 100,000 respectively. Hispan-
ics had similarly high rates of gonorrhea (2137 cases per
100,000) and Asian/Pacific Islanders had the lowest gon-
orrhea rates (865 cases per 100,000) in 2008. Among non-
MSM, African-Americans had case rates of gonorrhea at
least five fold higher than all other racial groups during
the study period (Figure 3B). The rate ratio of MSM/non-
MSM was highest among Asian/Pacific Islanders 36.8
(95% CI: 26.9-46.7) and Whites 28.5 (95% CI: 20.4-36.57),
and lowest among African-Americans 2.9 (95% CI: 2.1-
3.7) and Hispanics 16.8 (95% CI: 10.9-22.7) (Figure 4).
Like chlamydia, approximately 70% of gonorrhea cases
were diagnosed in City Clinic between 1999 and 2003 and
5% to 10% of cases diagnosed in primary care offices. By
2007, 58% of cases were diagnosed in City Clinic and 24%
were diagnosed in primary care offices. Among non-
MSM, approximately two thirds of gonorrhea cases were
diagnosed at City Clinic and hospital settings between
1999 and 2003. However, by 2007, 38% of cases were diag-
nosed in primary care offices and 15% diagnosed at either
City Clinic or hospital settings.
Discussion
In measurement of disease burden, rates are superior to
case counts as they account for the underlying population
at risk and provide a measure of disease intensity in a
sub-population. Often MSM specific STI rates are diffi-
cult to calculate given that population estimates of MSM
are often unavailable. Here we report on MSM and non-
MSM racial/ethnic specific rates of STIs in San Francisco.
Between 1999 and 2008, rates of MSM chlamydia and
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Figure 3 Rates of gonorrhea among men in San Francisco, 1999-2008. (A) Cases of gonorrhea among men who have sex with men (MSM) per 
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gonorrhea increased, while non-MSM rates of these STIs
remained largely stable. These increases in STIs are con-
sistent with previous reports in San Francisco and other
cities [11,14]. African-American, Hispanic, and White
MSM had similar rates of chlamydia and gonorrhea while
Asian/Pacific Islander MSM had the lowest rates during
the study period. The MSM/non-MSM ratio was lowest
for African-American men and highest for White and
Asian/Pacific Islander men. While African-American
MSM had comparable rates of chlamydia and gonorrhea
to other racial/ethnic groups, African American non-
MSM had rates up to five times higher than these groups.
Reducing racial disparities is a national public health
priority. STIs, specifically gonorrhea, represent some of
the largest racial/ethnic disparities among reportable
conditions [4]. Our data highlight not only the disparities
that exist across race and ethnicity, but also among sub-
populations of MSM and non-MSM. These data identify
important trends in chlamydia and gonorrhea morbidity
that are often masked when all male morbidity is exam-
ined without regard to sexual behavior.
Furthermore, the data presented here suggest that the
disparities paradigm be expanded to include sexual
behavior. For all racial/ethnic groups, MSM had signifi-
cantly higher rates of chlamydia and gonorrhea compared
to non-MSM. In San Francisco, MSM are significantly
burdened with STIs and these disparities warrant public
health attention and resources.
San Francisco STD Prevention and Control Services
recommends that all sexually active MSM be screened for
syphilis, chlamydia, and gonorrhea every three to six
months. In San Francisco, routine screening for gonor-
rhea and chlamydia at the urogenital, pharyngeal, and
rectal sites is widely available for MSM and has been
shown to lead to significantly higher rates of gonorrhea
and chlamydia diagnoses, primarily through diagnosis of
asymptomatic infections [15,16]. After increased rates of
syphilis were reported in 2001 and 2002, there have been
multiple public health campaigns for routine STI screen-
ing of MSM which may partially explain the increased
percentage of cases diagnosed in primary care offices
during our study period. Additionally, San Francisco STD
Prevention and Control Services has worked over the
prior decade to ensure that STD screening is incorpo-
rated into routine HIV care for MSM in San Francisco.
Based on lower sexual risk behavior such screening is
not routinely indicated in non-MSM and the higher rate
of STIs among African-American non-MSM in San Fran-
Figure 4 MSM/non-MSM ratio of gonorrhea in San Francisco, 1999-2008. MSM to non-MSM racial/ethnic specific rate ratios for gonorrhea.
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cisco, while previously documented, is not well under-
stood. Although several studies have shown that African-
American MSM are less likely compared to other racial
groups to self-identify as "gay" or "bisexual" we used data
on gender of sex partners and not sexual identity to
define MSM [17-19]. In addition, we found the percent-
age of African-American men classified as MSM was
similar to that of white and Hispanic men, which would
not support misclassification of sexual behavior as a suffi-
cient explanation. Sexual networks, social context, and
other contextual factors have been identified as impor-
tant factors in racial STI disparities in other regions of the
US [20-23]. It is unclear how these more macro level fac-
tors may function differently (if at all) between MSM and
non-MSM.
Our analysis has several limitations worth noting. Our
STI case rates and MSM/non-MSM ratios are dependent
on estimation of population sizes for both MSM and non-
MSM in San Francisco. Using the National NHBS and
2000 census data, we calculated a midpoint estimate and
assume that the size of each population is relatively stable
over the time period of analysis (1999-2008). Comparison
of the 2000 census data to the 2006-2008 American Com-
munity Survey data for San Francisco County did not
reveal any significant demographic shifts [24]. Further-
more, the NHBS sample size of MSM of color was too
small to make meaningful comparisons between groups
of MSM [25-29]. In the beginning of our study period, up
to 81% of chlamydia cases and 70% of gonorrhea cases
were diagnosed in the public STI clinic. There are data
that STI rates among MSM attending public STI clinics
are higher than other clinical sites which could lead to an
over estimation of STI rates [30,31]. However, we believe
that the gonorrhea and chlamydia surveillance systems in
San Francisco are robust, as electronic laboratory report-
ing has been integrated into routine surveillance activi-
ties. Additionally, our definition of MSM was considered
fixed. If a male patient reported male partners in 1990
during an STD clinic visit or public health disease control
interview, or on a morbidity report, all subsequent mor-
bidity was classified as MSM. As a result, men who have
not had recent male exposures would be misclassified as
MSM. Finally, San Francisco is a unique urban environ-
ment and is residence to a large population of MSM.
Therefore, these findings may have limited generalizibil-
ity. However, we believe the methods we employed could
be used in other health jurisdictions to develop locally
valuable measures of disease burden and disparity.
Conclusions
We capitalized on our existing data infrastructure and
locally available data to examine population-based esti-
mates of the rates of gonorrhea and chlamydia among
men in San Francisco. The rates of STIs among MSM
continue to rise, while the rates among non-MSM have
been stable. MSM carried a substantially higher burden
of STIs compared to non-MSM except among African-
American men. The lower MSM/non-MSM ratio among
African-Americans was driven primarily by the high rates
among African American non-MSM. This study was the
first population based estimate of the burden of gonor-
rhea and chlamydia among men in San Francisco. Utiliz-
ing the MSM population estimates of San Francisco and
sexual partner gender data acquired at the time of testing,
we report racial disparities that mirror those previously
documented in the literature. We also suggest that among
African-American men the gender of sexual partners is
less of a determinant of gonorrhea or chlamydia rates
than for other racial groups. This phenomenon warrants
further research to establish contributing factors in order
to develop effective, appropriate prevention strategies.
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